Mr. DiPiano is a General Partner of NewSpring Ventures and the Managing Partner of NewSpring Capital. Prior to joining NewSpring Capital, Mr. DiPiano was a serial entrepreneur and investor. He led or co-led the investment into six companies in the business services, healthcare and information technology industries. During that time, he was affiliated with Safeguard Scientifics (NYSE:SFG) and their related Funds. Prior to 1996, he spent six years as a division CEO and director of Chemical Leaman Corporation. Mr. DiPiano started his career in 1980 with Baxter Healthcare Corporation (NYSE: BAX) where he held numerous positions culminating as Vice President responsible for Operations and Sales of the Industrial Scientific Products Division. He currently serves on the boards of Femme Pharma; the Mid-Atlantic Capital Alliance, formerly known as the Greater Philadelphia Venture Group, which is a trade association representing over 80 Mid-Atlantic based private equity funds with approximately $12 billion under management, where he served as the 2005 program year Chairman; NutriSystem (NASDAQ: NTRI); Prescient Applied Intelligences (OTC BB: PPID); Bluenog; and the University City Science Center, where he sits on the investment committee.
